CLASS III Drug recall · Reported 4 Oct 2023 · FDA Enforcement Report

Clearasil Rapid Rescue Deep Treatment Pads (Salicylic Acid 2%) recalled

RB Health (US) is recalling Clearasil Rapid Rescue Deep Treatment Pads (Salicylic Acid 2%), distributed nationwide in the US. The recall was initiated on 29 Aug 2023 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot # KT220211, Exp 07/2024
NDC63824-431
UPC0839977009200
Quantity recalled6,072 cases/36,426 individual selling units

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1179-2023
FDA event ID
92977
Recalling firm
RB Health (US), Parsippany, NJ
Manufacturer
Reckitt Benckiser LLC
Classification
Class III
Status
Terminated
Recall initiated
29 Aug 2023
FDA classified
27 Sep 2023
Reported
4 Oct 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Labeling Errors

Timeline

29 Aug 2023Recall initiated by company
27 Sep 2023Classified by FDA+29 days
4 Oct 2023Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Labeling: Label Error on Declared Strength: The incorrect label on the back of the product packaging.

Product as listed by the FDA

Clearasil Rapid Rescue Deep Treatment Pads (Salicylic Acid 2%), packaged in 90-count plastic jar, further packaged in case of 6 jars per case, Distributed by RB Health (US), Parsippany, NJ 07054, NDC 63824-431-90

Where it was distributed

USA nationwide

Nationwide

Questions about this recall

Is Clearasil Rapid Rescue Deep Treatment Pads (Salicylic Acid 2%) recalled?

Yes. RB Health (US) recalled Clearasil Rapid Rescue Deep Treatment Pads (Salicylic Acid 2%) on 29 Aug 2023. The recall is Class III and its status is Terminated. Recall number D-1179-2023.

Why was it recalled?

Labeling: Label Error on Declared Strength: The incorrect label on the back of the product packaging.

Which lots are affected?

Lot # KT220211, Exp 07/2024

Where was it sold?

USA nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other Salicylic Acid recalls

All 4